Compare TMCI & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMCI | ASLE |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.6M | 309.5M |
| IPO Year | 2021 | 2018 |
| Metric | TMCI | ASLE |
|---|---|---|
| Price | $4.81 | $5.80 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 2 |
| Target Price | $4.77 | ★ $7.00 |
| AVG Volume (30 Days) | 358.7K | ★ 486.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.64 |
| EPS | N/A | ★ N/A |
| Revenue | $212,690,000.00 | ★ $335,286,000.00 |
| Revenue This Year | N/A | $23.41 |
| Revenue Next Year | $8.18 | $6.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $1.17 | $5.41 |
| 52 Week High | $7.42 | $8.92 |
| Indicator | TMCI | ASLE |
|---|---|---|
| Relative Strength Index (RSI) | 57.17 | 42.03 |
| Support Level | $3.84 | $5.57 |
| Resistance Level | $4.85 | $5.92 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 73.68 | 36.89 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.